B
Boundless Bio, Inc. (BOLD)
NMS – Real vaqt narxi. Valyuta: USD
1.50
-0.05 (-3.23%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
1.50
-0.05 (-3.23%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Boundless Bio, Inc., klinik bosqichdagi onkologiya kompaniyasi, onkogen amplifikatsiyalangan saraton kasalligi bo'lgan bemorlarni davolash uchun ekstranuklear DNK (ecDNA) yo'naltirilgan terapiyalarni ishlab chiqadi. Uning yetakchi mahsulot nomzodi BBI-940 bo'lib, u ecDNA yo'naltirilgan terapevtik nomzod (ecDTx) bo'lib, estrogen retseptorlari ijobiy va inson epidermis o'sish omili retseptorlari 2-negativ ko'krak bezi saratoni, shuningdek, uch marta salbiy ko'krak bezi saratoni luminal androgen retseptorlari subtipi bo'lgan bemorlarda 1/2-faza klinik sinovida. Kompaniya ilgari Pretzel Therapeutics, Inc. nomi bilan tanilgan va 2019-yil iyul oyida Boundless Bio, Inc. nomini o'zgartirgan. Boundless Bio, Inc. 2018-yilda tashkil etilgan va San-Diego, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Christian Hassig Ph.D. | Chief Scientific Officer |
| Dr. James L. Freddo M.D. | Interim Chief Medical Officer |
| Dr. Robert C. Doebele M.D., Ph.D. | Chief Medical Officer |
| Mr. David Hinkle | Senior VP of Finance, Controller & Corporate Treasurer |
| Mr. Zachary D. Hornby | CEO, President & Director |
| Ms. Amy Berkley Ph.D. | Senior Vice President of Program Team |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-08 | 10-Q | bold-20260331.htm |
| 2026-04-28 | DEFA14A | bold_defa14a_2026_.htm |
| 2026-04-13 | 8-K | bold-20260413.htm |
| 2026-03-09 | 8-K | bold-20260303.htm |
| 2025-11-05 | 8-K | bold-20251105.htm |
| 2025-11-05 | 10-Q | bold-20250930.htm |
| 2025-08-05 | 8-K | bold-20250805.htm |
| 2025-08-05 | 10-Q | bold-20250630.htm |
| 2025-06-23 | 8-K | bold-20250623.htm |
| 2025-05-23 | 8-K | bold-20250523.htm |
| Ms. Jessica Oien J.D. | Chief Legal Officer & Corporate Secretary |
| Ms. Meredith Wesley | Chief Human Resources Officer |